Skip to content

Education Against Tobacco Randomized Trial in Brazil

Education Against Tobacco: Medical-student-delivered Smoking Prevention Programme for Secondary Schools in Brazil - Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02725021
Enrollment
1500
Registered
2016-03-31
Start date
2016-10-31
Completion date
2018-04-30
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Prevention

Keywords

tobacco prevention

Brief summary

A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7-11th grade of secondary school. The primary endpoint is the change in smoking prevalence between the two groups.

Interventions

BEHAVIORALEducation Against Tobacco school-based intervention by medical students

Sponsors

University of Giessen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Visiting grades 7-11 of a regular public secondary school in Brazil.

Exclusion criteria

* Not fulfilling inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Smoking prevalence measured via questionnaire.12 months follow-up

Secondary

MeasureTime frame
Smoking onset: Difference in the number of new smokers at 12 months of follow-up who were not present at baselineBaseline and 12 months
Difference in the number of new non-smokers at 12 months of follow-up who were smoking at baselineBaseline and 12 months
Relevant differences due to the theory of planned behaviour between the two groups measured via questionnaire.Difference in attitude towards smoking between the two groups at 12 months follow-up measured via questionnaires.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026